Race Oncology |
High $1.29 |
Low $1.18 |
Trades 155 |
Turnover $303,224 |
Volume 249,053 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $307,828,256 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (9-Nov) 19,354 (0.01%) (577th) |
|
52w High $3.79 |
52w Low $1.40 |
P/E - |
EPS -0.06 |
Trading Policy Update
RAC released this announcement to the ASX on 13 October 2021, 17:56. The announcement is not marked as price sensitive, and is 8 page(s) in length and 134.7kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.014% short sold according to ASIC data. It was ranked the 588th most shorted stock on the ASX. It is now ranked as the 577th most shorted stock on the ASX with 0.010% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Trading Policy Update | 13 October 2021, 17:56 |
| Race secures fifth US patent for Zantrene | 6 October 2021, 9:17 |
| Date of AGM & Closing Date for Director Nominations | 5 October 2021, 9:25 |
| Preclinical & Clinical Programs Update | 30 September 2021, 17:38 |
If you were already registered, log in here.